Legato Capital Management LLC Sells 70,140 Shares of Myomo, Inc. (NYSEAMERICAN:MYO)

Legato Capital Management LLC cut its stake in Myomo, Inc. (NYSEAMERICAN:MYO) by 22.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 237,131 shares of the company’s stock after selling 70,140 shares during the period. Legato Capital Management LLC owned approximately 0.78% of Myomo worth $1,527,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Barclays PLC bought a new position in Myomo in the third quarter valued at $36,000. Jane Street Group LLC acquired a new position in shares of Myomo during the 3rd quarter worth about $65,000. Vontobel Holding Ltd. bought a new position in shares of Myomo in the 3rd quarter valued at about $90,000. Calamos Advisors LLC acquired a new stake in shares of Myomo in the fourth quarter valued at about $189,000. Finally, XTX Topco Ltd acquired a new stake in shares of Myomo in the third quarter valued at about $149,000. Institutional investors own 44.99% of the company’s stock.

Analysts Set New Price Targets

MYO has been the topic of several recent analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $7.50 price target on shares of Myomo in a research report on Wednesday, November 13th. Craig Hallum raised their target price on shares of Myomo from $7.00 to $9.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Finally, Ascendiant Capital Markets upped their price target on shares of Myomo from $8.50 to $9.00 and gave the stock a “buy” rating in a research report on Tuesday, November 12th.

Myomo Stock Up 5.4 %

Shares of NYSEAMERICAN MYO opened at $6.29 on Thursday. Myomo, Inc. has a 1-year low of $2.51 and a 1-year high of $7.17.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.